After the Food and Drug Administration initially expressed concern about the high cancer rates among clinical study patients receiving Medtronic's Amplify for posterlateral lumbar fusion, the FDA's Orthopaedic and Rehabilitation Devices panel voted 6-5 in favor of approval, according to…
The Latest
The FDA issued 39 orthopedic- and spine-related 510(k) clearances in June, according to an FDA report.
Steven Ballinger, MD, has joined the team at Samaritan Mid-Valley Orthopedics in Albany, Ore., according to a Democrat-Herald report.
Thomas Graham, MD, has been named Cleveland Clinic Innovations chairman, according to a Medcity News report.
John Dietz, MD, chairman of Indiana Orthopaedic Hospital in Indianapolis, discusses four successful cost-reduction strategies.
The U.S. Food and Drug Administration is concerned about the high number of cancer cases reported in clinical study patients for Medtronic's Amplify, a spine device, according to a Wall Street Journal report.
A Mount Sinai School of Medicine study published in Orthopedics found that the average total knee or hip replacement surgery patient experiences a significant decrease in weight and body mass index, according to a hospital news release.
Indiana Orthopaedic Hospital has partnered with InVivoLink to collect clinical, financial and operational data directly from the operating room at the point of service, according to an InVivoLink news report.
The FDA issued 30 orthopedic- and spine-related 510(k) clearances in May, according to a report by the FDA.
Michael Pryce, MD, an orthopedic surgeon in Ohio, is running for the U.S. Senate seat made vacant by the retirement of Senator George Voinovich.